EP2747562A4 - Estrogen receptor ligands and methods of use thereof - Google Patents
Estrogen receptor ligands and methods of use thereofInfo
- Publication number
- EP2747562A4 EP2747562A4 EP12834287.0A EP12834287A EP2747562A4 EP 2747562 A4 EP2747562 A4 EP 2747562A4 EP 12834287 A EP12834287 A EP 12834287A EP 2747562 A4 EP2747562 A4 EP 2747562A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- estrogen receptor
- receptor ligands
- ligands
- estrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/215,679 US9427418B2 (en) | 2009-02-23 | 2011-08-23 | Estrogen receptor ligands and methods of use thereof |
PCT/US2012/052141 WO2013043304A1 (en) | 2009-02-23 | 2012-08-23 | Estrogen receptor ligands and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2747562A1 EP2747562A1 (en) | 2014-07-02 |
EP2747562A4 true EP2747562A4 (en) | 2015-05-06 |
Family
ID=48444651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12834287.0A Withdrawn EP2747562A4 (en) | 2011-08-23 | 2012-08-23 | Estrogen receptor ligands and methods of use thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2747562A4 (en) |
JP (1) | JP2014524479A (en) |
KR (1) | KR20140064906A (en) |
CN (1) | CN103957706A (en) |
AU (1) | AU2012312902B2 (en) |
CA (1) | CA2845890A1 (en) |
IL (1) | IL231070A0 (en) |
IN (1) | IN2014DN01959A (en) |
MX (1) | MX2014002105A (en) |
RU (1) | RU2014111060A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019063705A1 (en) * | 2017-09-27 | 2019-04-04 | Targimmune Therapeutics Ag | Castration resistant prostate cancer |
MX2021009119A (en) * | 2019-02-01 | 2022-01-18 | Fond Per Listituto Oncologico Di Ricerca Ior | Methods of treating castrate-resistant prostate cancer. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007062230A2 (en) * | 2005-11-28 | 2007-05-31 | Gtx, Inc. | Nuclear receptor binding agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8546451B2 (en) * | 2005-11-28 | 2013-10-01 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
US8158828B2 (en) * | 2005-11-28 | 2012-04-17 | Gtx, Inc. | Nuclear receptor binding agents |
RU2543339C2 (en) * | 2009-02-23 | 2015-02-27 | ДЖиТиЭкс, ИНК. | Oestrogen receptor ligands and methods of using them |
-
2012
- 2012-08-23 MX MX2014002105A patent/MX2014002105A/en unknown
- 2012-08-23 EP EP12834287.0A patent/EP2747562A4/en not_active Withdrawn
- 2012-08-23 RU RU2014111060/15A patent/RU2014111060A/en not_active Application Discontinuation
- 2012-08-23 KR KR1020147007549A patent/KR20140064906A/en not_active Application Discontinuation
- 2012-08-23 CN CN201280051979.4A patent/CN103957706A/en active Pending
- 2012-08-23 CA CA2845890A patent/CA2845890A1/en not_active Abandoned
- 2012-08-23 IN IN1959DEN2014 patent/IN2014DN01959A/en unknown
- 2012-08-23 AU AU2012312902A patent/AU2012312902B2/en not_active Ceased
- 2012-08-23 JP JP2014527312A patent/JP2014524479A/en active Pending
-
2014
- 2014-02-20 IL IL231070A patent/IL231070A0/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007062230A2 (en) * | 2005-11-28 | 2007-05-31 | Gtx, Inc. | Nuclear receptor binding agents |
Also Published As
Publication number | Publication date |
---|---|
EP2747562A1 (en) | 2014-07-02 |
RU2014111060A (en) | 2015-09-27 |
KR20140064906A (en) | 2014-05-28 |
CA2845890A1 (en) | 2013-03-28 |
IL231070A0 (en) | 2014-03-31 |
AU2012312902A1 (en) | 2013-05-23 |
IN2014DN01959A (en) | 2015-05-15 |
AU2012312902B2 (en) | 2016-03-17 |
JP2014524479A (en) | 2014-09-22 |
CN103957706A (en) | 2014-07-30 |
MX2014002105A (en) | 2014-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284407B (en) | Opioid receptor ligands and methods of using and making same | |
HK1255608A1 (en) | Anti-htra1 antibodies and methods of use | |
ZA201501858B (en) | Anti-mcam antibodies and associated methods of use | |
ZA201403760B (en) | Anti-cd98 antibodies and methods of use thereof | |
HK1201843A1 (en) | Anti-polyubiquitin antibodies and methods of use | |
IL230901A0 (en) | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | |
EP2776437A4 (en) | Modulators of opioid receptors and methods of use thereof | |
IL214805A0 (en) | Estrogen receptor ligands and methods of use thereof | |
EP2538780A4 (en) | Estrogen receptor ligands and methods of use thereof | |
EP2709999A4 (en) | Quinazoline-7-ether compounds and methods of use | |
EP2747562A4 (en) | Estrogen receptor ligands and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140305 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150408 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 35/00 20060101ALI20150331BHEP Ipc: A61K 45/06 20060101ALI20150331BHEP Ipc: A61K 31/167 20060101AFI20150331BHEP Ipc: A61K 31/137 20060101ALI20150331BHEP Ipc: A61K 31/4453 20060101ALI20150331BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20180301 |